Skip to main content
Erschienen in: Supportive Care in Cancer 3/2013

01.03.2013 | Original Article

The fall rate of older community-dwelling cancer patients

verfasst von: Martine T. E. Puts, Johanne Monette, Veronique Girre, Christina Wolfson, Michèle Monette, Gerald Batist, Howard Bergman

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little is known about the incidence of falls in cancer patients receiving cancer treatment. The aims were to explore the number of falls older adults report in the 6 months after cancer diagnosis, and if those with a fall were more frail than those who did not fall.

Methods

Secondary data analysis of a prospective pilot study that recruited patients aged 65 and older with a new cancer diagnosis. At each interview (baseline, 3- and 6-month follow-up), participants were asked if they had a fall in the previous 3 months. The frailty markers and functional status were obtained at baseline, 3- and 6-month follow-up. Chi-square and t tests were used to compare those who had a fall to those who had no fall. Univariate logistic regression analysis was conducted to explore the association between sociodemographic and health characteristics and reporting a fall.

Results

Seventeen participants (18.7 %) reported one or more falls in the first 6 months after cancer diagnosis. Fifteen participants reported one or more falls in the 3 months prior to the cancer diagnosis. Those who had a fall and those with no fall were not different in terms of health and functioning. None of the sociodemographic and health characteristics including the frailty markers were associated with a fall.

Conclusion

A fall is common in cancer patients. More research is needed to examine the risk factors for a fall in older adults receiving cancer treatment.
Literatur
1.
Zurück zum Zitat World Health Organization. WHO global report on falls prevention in older age. WHO Press, Geneva World Health Organization. WHO global report on falls prevention in older age. WHO Press, Geneva
2.
Zurück zum Zitat Division of Aging and Seniors, Public Health Agency of Canada (2005) Report on seniors’ falls in Canada. Ottawa: Minister of Public Works and Government Services Canada Division of Aging and Seniors, Public Health Agency of Canada (2005) Report on seniors’ falls in Canada. Ottawa: Minister of Public Works and Government Services Canada
3.
Zurück zum Zitat Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765PubMedCrossRef Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765PubMedCrossRef
4.
Zurück zum Zitat Holley S (2002) A look at the problem of falls among people with cancer. Clin J Oncol Nurs 6(4):193–197PubMedCrossRef Holley S (2002) A look at the problem of falls among people with cancer. Clin J Oncol Nurs 6(4):193–197PubMedCrossRef
5.
Zurück zum Zitat Chen Z, Maricic M, Aragaki AK, Mouton C, Arendell L, Lopez AM, Bassford T, Chlebowski RT (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the women’s health initiative. Osteoporos Int 20(4):527–536PubMedCrossRef Chen Z, Maricic M, Aragaki AK, Mouton C, Arendell L, Lopez AM, Bassford T, Chlebowski RT (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the women’s health initiative. Osteoporos Int 20(4):527–536PubMedCrossRef
6.
Zurück zum Zitat Tofthagen C, McAllister RD, McMillan SC (2011) Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clin J Oncol Nurs 15(2):182–188PubMedCrossRef Tofthagen C, McAllister RD, McMillan SC (2011) Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clin J Oncol Nurs 15(2):182–188PubMedCrossRef
7.
Zurück zum Zitat Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583–589PubMedCrossRef Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583–589PubMedCrossRef
8.
Zurück zum Zitat DeMott TK, Richardson JK, Thies SB, Ashton-Miller JA (2007) Falls and gait characteristics among older persons with peripheral neuropathy. Am J Phys Med Rehabil 86(2):125–132PubMedCrossRef DeMott TK, Richardson JK, Thies SB, Ashton-Miller JA (2007) Falls and gait characteristics among older persons with peripheral neuropathy. Am J Phys Med Rehabil 86(2):125–132PubMedCrossRef
9.
Zurück zum Zitat Limburg CE (2007) Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer. Oncol Nurs Forum 34(1):55–63PubMedCrossRef Limburg CE (2007) Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer. Oncol Nurs Forum 34(1):55–63PubMedCrossRef
10.
Zurück zum Zitat Bylow K, Hemmerich J, Mohile SG, Stadler WM, Sajid S, Dale W (2011) Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case–control study. Urology 77(4):934–940PubMedCrossRef Bylow K, Hemmerich J, Mohile SG, Stadler WM, Sajid S, Dale W (2011) Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case–control study. Urology 77(4):934–940PubMedCrossRef
11.
Zurück zum Zitat Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG (2008) Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology 72(2):422–427PubMedCrossRef Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG (2008) Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology 72(2):422–427PubMedCrossRef
12.
Zurück zum Zitat Overcash J (2007) Prediction of falls in older adults with cancer: a preliminary study. Oncol Nurs Forum 34(2):341–346PubMedCrossRef Overcash J (2007) Prediction of falls in older adults with cancer: a preliminary study. Oncol Nurs Forum 34(2):341–346PubMedCrossRef
13.
Zurück zum Zitat Overcash JA, Beckstead J (2008) Predicting falls in older patients using components of a comprehensive geriatric assessment. Clin J Oncol Nurs 12(6):941–949PubMedCrossRef Overcash JA, Beckstead J (2008) Predicting falls in older patients using components of a comprehensive geriatric assessment. Clin J Oncol Nurs 12(6):941–949PubMedCrossRef
14.
Zurück zum Zitat Hussain S, Breunis H, Timilshina N, Alibhai SMH (2010) Falls in men on androgen deprivation therapy for prostate cancer. J Geriatr Oncol 1(1):32–39CrossRef Hussain S, Breunis H, Timilshina N, Alibhai SMH (2010) Falls in men on androgen deprivation therapy for prostate cancer. J Geriatr Oncol 1(1):32–39CrossRef
15.
Zurück zum Zitat Stone C, Lawlor PG, Nolan B, Kenny RA (2011) A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manag 42(4):535–540CrossRef Stone C, Lawlor PG, Nolan B, Kenny RA (2011) A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manag 42(4):535–540CrossRef
16.
Zurück zum Zitat Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, Mcburnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156PubMedCrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, Mcburnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156PubMedCrossRef
17.
Zurück zum Zitat Ensrud KE, Ewing SK, Cawthon PM, Fink HA, Taylor BC, Cauley JA, Dam TT, Marshall LM, Orwoll ES, Cummings SR, Osteoporotic Fractures in Men Research Group (2009) A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 57(3):492–498PubMedCrossRef Ensrud KE, Ewing SK, Cawthon PM, Fink HA, Taylor BC, Cauley JA, Dam TT, Marshall LM, Orwoll ES, Cummings SR, Osteoporotic Fractures in Men Research Group (2009) A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 57(3):492–498PubMedCrossRef
18.
Zurück zum Zitat Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, Cauley JA, Hochberg MC, Rodondi N, Tracy JK, Cummings SR (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 168(4):382–389PubMedCrossRef Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, Cauley JA, Hochberg MC, Rodondi N, Tracy JK, Cummings SR (2008) Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 168(4):382–389PubMedCrossRef
19.
Zurück zum Zitat Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM, for the Study of Osteoporotic Fractures Research Group (2007) Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 62(7):744–751PubMedCrossRef Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM, for the Study of Osteoporotic Fractures Research Group (2007) Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 62(7):744–751PubMedCrossRef
20.
Zurück zum Zitat Puts MT, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H (2009) Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retention. BMC Cancer 9(1):277PubMedCrossRef Puts MT, Monette J, Girre V, Wolfson C, Monette M, Batist G, Bergman H (2009) Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retention. BMC Cancer 9(1):277PubMedCrossRef
21.
Zurück zum Zitat Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C (2007) Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci 62(1079–5006; 7):731–737PubMedCrossRef Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C (2007) Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci 62(1079–5006; 7):731–737PubMedCrossRef
22.
Zurück zum Zitat Bergman H, Béland F, Karunananthan S, Hummel S, Hogan D, Wolfson C (2004) Développement d’un cadre de travail pour comprendre et étudier la fragilité. Gerontol Soc 109:15–29 Bergman H, Béland F, Karunananthan S, Hummel S, Hogan D, Wolfson C (2004) Développement d’un cadre de travail pour comprendre et étudier la fragilité. Gerontol Soc 109:15–29
23.
Zurück zum Zitat Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54(0002–8614; 5):743–749PubMedCrossRef Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54(0002–8614; 5):743–749PubMedCrossRef
24.
Zurück zum Zitat Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49(2):M85–M94PubMedCrossRef Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49(2):M85–M94PubMedCrossRef
25.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRef
26.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(0002–8614; 4):695–699PubMedCrossRef Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(0002–8614; 4):695–699PubMedCrossRef
27.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(0001–690; 6):361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(0001–690; 6):361–370PubMedCrossRef
28.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
29.
Zurück zum Zitat Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281(6):558–560PubMedCrossRef Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L (1999) Midlife hand grip strength as a predictor of old age disability. JAMA 281(6):558–560PubMedCrossRef
30.
Zurück zum Zitat Davis HS, MacPherson K, Merry HR, Wentzel C, Rockwood K (2001) Reliability and validity of questions about exercise in the Canadian study of health and aging. Int Psychogeriatr 13(Supp 1(1041–6102)):177–182PubMedCrossRef Davis HS, MacPherson K, Merry HR, Wentzel C, Rockwood K (2001) Reliability and validity of questions about exercise in the Canadian study of health and aging. Int Psychogeriatr 13(Supp 1(1041–6102)):177–182PubMedCrossRef
31.
Zurück zum Zitat Groll DL, To T, Bombardier C, Wright JG (2005) The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58(6):595–602PubMedCrossRef Groll DL, To T, Bombardier C, Wright JG (2005) The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58(6):595–602PubMedCrossRef
32.
Zurück zum Zitat Fillenbaum GG, Smyer MA (1981) The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 36(4):428–434PubMedCrossRef Fillenbaum GG, Smyer MA (1981) The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 36(4):428–434PubMedCrossRef
33.
Zurück zum Zitat Katz S (1983) Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 31(0002–8614; 12):721–727PubMed Katz S (1983) Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 31(0002–8614; 12):721–727PubMed
34.
Zurück zum Zitat Collaborative Staging Task Force of the American Joint Committee on Cancer (2004) Collaborative staging manual and coding instructions, version 01.04.00. Chicago, IL: Jointly published by the American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services (Bethesda, MD); NIH Publication Number 04–5496 Collaborative Staging Task Force of the American Joint Committee on Cancer (2004) Collaborative staging manual and coding instructions, version 01.04.00. Chicago, IL: Jointly published by the American Joint Committee on Cancer (Chicago, IL) and U.S. Department of Health and Human Services (Bethesda, MD); NIH Publication Number 04–5496
35.
Zurück zum Zitat Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31(11):1860–1861PubMed Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31(11):1860–1861PubMed
36.
Zurück zum Zitat Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854PubMedCrossRef Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854PubMedCrossRef
37.
Zurück zum Zitat Johansson BB, Holmberg L, Berglund IG, Sjoden PO, Glimelius BL (2004) Determinants of cancer patients’ utilization of hospital care within two years after diagnosis. Acta Oncol 43(6):536–544PubMedCrossRef Johansson BB, Holmberg L, Berglund IG, Sjoden PO, Glimelius BL (2004) Determinants of cancer patients’ utilization of hospital care within two years after diagnosis. Acta Oncol 43(6):536–544PubMedCrossRef
38.
Zurück zum Zitat Puts MT, Monette J, Girre V, Pepe C, Monette M, Assouline S, Panasci L, Basik M, Miller WH Jr, Batist G, Wolfson C, Bergman H (2011) Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 78(2):138–149PubMedCrossRef Puts MT, Monette J, Girre V, Pepe C, Monette M, Assouline S, Panasci L, Basik M, Miller WH Jr, Batist G, Wolfson C, Bergman H (2011) Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol 78(2):138–149PubMedCrossRef
39.
Zurück zum Zitat Common terminology criteria for adverse events (CTCAE) version 3.0. 2006. Common terminology criteria for adverse events (CTCAE) version 3.0. 2006.
40.
Zurück zum Zitat (2009) Reducing injuries from medication-related falls by generating targeted computerized alerts for high risk patients within an electronic prescribing system. Montreal: Canadian Patient Safety Institute (2009) Reducing injuries from medication-related falls by generating targeted computerized alerts for high risk patients within an electronic prescribing system. Montreal: Canadian Patient Safety Institute
41.
Zurück zum Zitat Puts MT, Monette J, Girre V, Costa-Lima B, Wolfson C, Batist G, Bergman H (2010) Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study. Drugs Aging 27(7):559–572PubMedCrossRef Puts MT, Monette J, Girre V, Costa-Lima B, Wolfson C, Batist G, Bergman H (2010) Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study. Drugs Aging 27(7):559–572PubMedCrossRef
42.
Zurück zum Zitat Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, Fox M, Guralnik JM (2003) Physical performance measures in the clinical setting. J Am Geriatr Soc 51(0002–8614; 3):314–322PubMedCrossRef Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, Fox M, Guralnik JM (2003) Physical performance measures in the clinical setting. J Am Geriatr Soc 51(0002–8614; 3):314–322PubMedCrossRef
43.
Zurück zum Zitat Sourial N, Bergman H, Karunananthan S, Wolfson C, Guralnik J, Payette H, Gutierrez-Robledo L, Deeg DJ, Fletcher JD, Puts MT, Zhu B, Beland F. Contribution of frailty markers in explaining differences among individuals in five samples of older persons. J Gerontol A Biol Sci Med Sci. 2012 Mar 28 (in press) Sourial N, Bergman H, Karunananthan S, Wolfson C, Guralnik J, Payette H, Gutierrez-Robledo L, Deeg DJ, Fletcher JD, Puts MT, Zhu B, Beland F. Contribution of frailty markers in explaining differences among individuals in five samples of older persons. J Gerontol A Biol Sci Med Sci. 2012 Mar 28 (in press)
44.
Zurück zum Zitat Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. (Summary of the updated American geriatrics Society/British geriatrics society clinical practice guideline for prevention of falls in older persons) J Am Geriatr Soc 2011;59(1):148–57 Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. (Summary of the updated American geriatrics Society/British geriatrics society clinical practice guideline for prevention of falls in older persons) J Am Geriatr Soc 2011;59(1):148–57
45.
Zurück zum Zitat Overcash JA, Rivera HR, Van Schaick J (2010) An analysis of falls experienced by older adult patients diagnosed with cancer. Oncol Nurs Forum 37(5):573–580PubMedCrossRef Overcash JA, Rivera HR, Van Schaick J (2010) An analysis of falls experienced by older adult patients diagnosed with cancer. Oncol Nurs Forum 37(5):573–580PubMedCrossRef
Metadaten
Titel
The fall rate of older community-dwelling cancer patients
verfasst von
Martine T. E. Puts
Johanne Monette
Veronique Girre
Christina Wolfson
Michèle Monette
Gerald Batist
Howard Bergman
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1579-4

Weitere Artikel der Ausgabe 3/2013

Supportive Care in Cancer 3/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.